Literature DB >> 18222232

Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes.

Peyman Sardari Nia1, Cecile Colpaert, Peter Vermeulen, Joost Weyler, Francesco Pezzella, Paul Van Schil, Eric Van Marck.   

Abstract

BACKGROUND: We have recently shown the prognostic value of growth pattern classification in non-small cell lung cancer. The aim of this study is to validate the hypothesis that these growth patterns have a distinct angiogenic and proliferative profile.
METHODS: Hematoxylin-eosin stained tissue sections of 239 patients with non-small cell lung cancer were classified into growth patterns. One representative tissue section per patient was double immunostained with CD34 and Ki-67 antibodies. Endothelial cell proliferation fraction, tumor cell proliferation fraction, microvessel density, and Chalkley count were assessed at the invading front and the center of the selected tumor section.
RESULTS: According to the growth pattern classification, 161 patients (67.4%) had a destructive, 33 (13.8%) a papillary, and 45 (18.8%) an alveolar growth pattern. There were significant differences in endothelial cell proliferation fraction (p < 0.001), tumor cell proliferation fraction (p < 0.001), microvessel density (p < 0.001), and Chalkley count (p < 0.001) between the growth patterns. Multiple Cox regression analysis showed that a low endothelial cell proliferation fraction was consistently an independent prognostic factor for overall poor (hazard ratio = 0.93; confidence interval: 0.88 to 0.97, p = 0.002) and disease-free survival (hazard ratio = 0.94; confidence interval: 0.89 to 0.98, p = 0.007).
CONCLUSIONS: Growth patterns have a distinct angiogenic and proliferative profile. In non-small cell lung cancer, a low degree of angiogenesis (a low endothelial cell proliferation fraction) is associated with poor prognosis.

Entities:  

Mesh:

Year:  2008        PMID: 18222232     DOI: 10.1016/j.athoracsur.2007.08.054

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas.

Authors:  Kyuichi Kadota; Jun-Ichi Nitadori; Camelia S Sima; Hideki Ujiie; Nabil P Rizk; David R Jones; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2015-05       Impact factor: 15.609

2.  Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.

Authors:  J Scott Brockenbrough; Janice K Morihara; Stephen E Hawes; Joshua E Stern; Janet S Rasey; Linda W Wiens; Qinghua Feng; Hubert Vesselle
Journal:  J Histochem Cytochem       Date:  2009-08-03       Impact factor: 2.479

Review 3.  Vessel co-option in cancer.

Authors:  Elizabeth A Kuczynski; Peter B Vermeulen; Francesco Pezzella; Robert S Kerbel; Andrew R Reynolds
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

Review 4.  Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?

Authors:  Tom Donnem; Jiangting Hu; Mary Ferguson; Omanma Adighibe; Cameron Snell; Adrian L Harris; Kevin C Gatter; Francesco Pezzella
Journal:  Cancer Med       Date:  2013-07-08       Impact factor: 4.452

5.  Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.

Authors:  Victoria L Bridgeman; Peter B Vermeulen; Shane Foo; Agnes Bilecz; Frances Daley; Eleftherios Kostaras; Mark R Nathan; Elaine Wan; Sophia Frentzas; Thomas Schweiger; Balazs Hegedus; Konrad Hoetzenecker; Ferenc Renyi-Vamos; Elizabeth A Kuczynski; Naveen S Vasudev; James Larkin; Martin Gore; Harold F Dvorak; Sandor Paku; Robert S Kerbel; Balazs Dome; Andrew R Reynolds
Journal:  J Pathol       Date:  2016-12-29       Impact factor: 7.996

6.  Convolutional neural networks can accurately distinguish four histologic growth patterns of lung adenocarcinoma in digital slides.

Authors:  Arkadiusz Gertych; Zaneta Swiderska-Chadaj; Zhaoxuan Ma; Nathan Ing; Tomasz Markiewicz; Szczepan Cierniak; Hootan Salemi; Samuel Guzman; Ann E Walts; Beatrice S Knudsen
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

Review 7.  Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases.

Authors:  Gwendolyn Haas; Shuang Fan; Michael Ghadimi; Tiago De Oliveira; Lena-Christin Conradi
Journal:  Front Cell Dev Biol       Date:  2021-04-12

Review 8.  Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma.

Authors:  Funto A Akindona; Stephen C Frederico; John C Hancock; Mark R Gilbert
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

9.  Histopathological growth pattern, proteolysis and angiogenesis in chemonaive patients resected for multiple colorectal liver metastases.

Authors:  Rikke Løvendahl Eefsen; Gert G Van den Eynden; Gunilla Høyer-Hansen; Pnina Brodt; Ole Didrik Laerum; Peter B Vermeulen; Ib Jarle Christensen; André Wettergren; Birgitte Federspiel; Gro L Willemoe; Ben Vainer; Kell Osterlind; Martin Illemann
Journal:  J Oncol       Date:  2012-08-02       Impact factor: 4.375

Review 10.  Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?

Authors:  Ana Luísa Coelho; Mónica Patrícia Gomes; Raquel Jorge Catarino; Christian Rolfo; Agostinho Marques Lopes; Rui Manuel Medeiros; António Manuel Araújo
Journal:  Oncotarget       Date:  2017-06-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.